{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:41:51Z","timestamp":1792798911478,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/mp.2016.120","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T04:04:53Z","timestamp":1471320293000},"page":"527-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":869,"title":["HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition"],"prefix":"10.1038","volume":"22","author":[{"given":"J","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lembke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1846-6920","authenticated-orcid":false,"given":"L","family":"Lazzeroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"G M","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Schatzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"BFmp2016120_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0022-3956(00)00035-2","volume":"34","author":"PD Patel","year":"2000","unstructured":"Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF . Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res 2000; 34: 383\u2013392.","journal-title":"J Psychiatr Res"},{"key":"BFmp2016120_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0166-2236(99)01438-1","volume":"22","author":"ER de Kloet","year":"1999","unstructured":"de Kloet ER, Oitzl MS, Joels M . Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci 1999; 22: 422\u2013426.","journal-title":"Trends Neurosci"},{"key":"BFmp2016120_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0306-4530(87)90040-0","volume":"12","author":"ER de Kloet","year":"1987","unstructured":"de Kloet ER, Reul JM . Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987; 12: 83\u2013105.","journal-title":"Psychoneuroendocrinology"},{"key":"BFmp2016120_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/archpsyc.60.1.24","volume":"60","author":"EA Young","year":"2003","unstructured":"Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H . Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 2003; 60: 24\u201328.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2016120_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","volume":"23","author":"F Holsboer","year":"2000","unstructured":"Holsboer F . The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23: 477\u2013501.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2016120_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0960-0760(91)90312-S","volume":"38","author":"BE Murphy","year":"1991","unstructured":"Murphy BE . Steroids and depression. J Steroid Biochem Mol Biol 1991; 38: 537\u2013559.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFmp2016120_CR7","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0024-3205(97)00926-0","volume":"61","author":"M Deuschle","year":"1997","unstructured":"Deuschle M, Gotthardt U, Schweiger U, Weber B, Korner A, Schmider J et al. With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens. Life Sci 1997; 61: 2239\u20132246.","journal-title":"Life Sci"},{"key":"BFmp2016120_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/archpsyc.1985.01790320069009","volume":"42","author":"B Pfohl","year":"1985","unstructured":"Pfohl B, Sherman B, Schlechte J, Stone R . Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 1985; 42: 897\u2013903.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2016120_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0006-3223(95)00451-3","volume":"40","author":"R Yehuda","year":"1996","unstructured":"Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ . Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 1996; 40: 79\u201388.","journal-title":"Biol Psychiatry"},{"key":"BFmp2016120_CR10","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1176\/appi.ajp.158.10.1612","volume":"158","author":"JK Belanoff","year":"2001","unstructured":"Belanoff JK, Kalehzan M, Sund B, Fleming Ficek SK, Schatzberg AF . Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry 2001; 158: 1612\u20131616.","journal-title":"Am J Psychiatry"},{"key":"BFmp2016120_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biopsych.2005.10.014","volume":"60","author":"J Keller","year":"2006","unstructured":"Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 2006; 60: 275\u2013281.","journal-title":"Biol Psychiatry"},{"key":"BFmp2016120_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.psyneuen.2012.05.006","volume":"38","author":"A Lembke","year":"2013","unstructured":"Lembke A, Gomez R, Tenakoon L, Keller J, Cohen G, Williams GH et al. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology 2013; 38: 115\u2013121.","journal-title":"Psychoneuroendocrinology"},{"key":"BFmp2016120_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1176\/ajp.154.11.1497","volume":"154","author":"JC Nelson","year":"1997","unstructured":"Nelson JC, Davis JM . DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 1997; 154: 1497\u20131503.","journal-title":"Am J Psychiatry"},{"key":"BFmp2016120_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/eje.0.1510397","volume":"151","author":"C Grossmann","year":"2004","unstructured":"Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF et al. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol 2004; 151: 397\u2013406.","journal-title":"Eur J Endocrinol"},{"key":"BFmp2016120_CR15","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock PL, Roiser JP, Riedel WJ, Blackwell AD . Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 2014; 44: 2029\u20132049.","journal-title":"Psychol Med"},{"key":"BFmp2016120_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.biopsych.2005.11.010","volume":"60","author":"RG Gomez","year":"2006","unstructured":"Gomez RG, Fleming SH, Keller J, Flores B, Kenna H, DeBattista C et al. The neuropsychological profile of psychotic major depression and its relation to cortisol. Biol Psychiatry 2006; 60: 472\u2013478.","journal-title":"Biol Psychiatry"},{"key":"BFmp2016120_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0735-7044.113.3.420","volume":"113","author":"SJ Lupien","year":"1999","unstructured":"Lupien SJ, Gillin CJ, Hauger RL . Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci 1999; 113: 420\u2013430.","journal-title":"Behav Neurosci"},{"key":"BFmp2016120_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tins.2007.10.005","volume":"31","author":"M Joels","year":"2008","unstructured":"Joels M, Karst H, DeRijk R, de Kloet ER . The coming out of the brain mineralocorticoid receptor. Trends Neurosci 2008; 31: 1\u20137.","journal-title":"Trends Neurosci"},{"key":"BFmp2016120_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/npp.2012.254","volume":"38","author":"U Rimmele","year":"2013","unstructured":"Rimmele U, Besedovsky L, Lange T, Born J . Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology 2013; 38: 884\u2013894.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2016120_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/npp.2014.181","volume":"40","author":"C Otte","year":"2014","unstructured":"Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A et al. Mineralorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individucoals. Neuropsychopharmacology 2014; 40: 386\u2013393.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2016120_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jpsychires.2009.10.006","volume":"44","author":"C Otte","year":"2010","unstructured":"Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res 2010; 44: 339\u2013346.","journal-title":"J Psychiatr Res"},{"key":"BFmp2016120_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jpsychires.2012.11.002","volume":"47","author":"A Medina","year":"2013","unstructured":"Medina A, Seasholtz AF, Sharma V, Burke S, Bunney W Jr., Myers RM et al. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J Psychiatr Res 2013; 47: 307\u2013314.","journal-title":"J Psychiatr Res"},{"key":"BFmp2016120_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/187152706778559273","volume":"5","author":"PJ Lucassen","year":"2006","unstructured":"Lucassen PJ, Heine VM, Muller MB, van der Beek EM, Wiegant VM, De Kloet ER et al. Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 2006; 5: 531\u2013546.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"BFmp2016120_CR24","doi-asserted-by":"crossref","unstructured":"Bortoluzzi A, Salum GA, Blaya C, Silveira PP, Grassi-Oliveira R, Dias da Rosa E et al. Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF. J Psychiatr Res 2014.","DOI":"10.1016\/j.jpsychires.2014.08.022"},{"key":"BFmp2016120_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3233\/JAD-140054","volume":"41","author":"J Sun","year":"2014","unstructured":"Sun J, Song F, Wang J, Han G, Bai Z, Xie B et al. Hidden risk genes with high-order intragenic epistasis in Alzheimer's disease. J Alzheimers Dis 2014; 41: 1039\u20131056.","journal-title":"J Alzheimers Dis"},{"key":"BFmp2016120_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/0006-8993(91)91612-5","volume":"561","author":"JR Seckl","year":"1991","unstructured":"Seckl JR, Dickson KL, Yates C, Fink G . Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res 1991; 561: 332\u2013337.","journal-title":"Brain Res"},{"key":"BFmp2016120_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.mce.2011.05.005","volume":"350","author":"EP Gomez-Sanchez","year":"2012","unstructured":"Gomez-Sanchez EP, Gomez-Sanchez CE . Central regulation of blood pressure by the mineralocorticoid receptor. Mol Cell Endocrinol 2012; 350: 289\u2013298.","journal-title":"Mol Cell Endocrinol"},{"key":"BFmp2016120_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3233\/JAD-2010-100663","volume":"22","author":"FJ Gil-Bea","year":"2010","unstructured":"Gil-Bea FJ, Aisa B, Solomon A, Solas M, del Carmen Mugueta M, Winblad B et al. HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease. J Alzheimers Dis 2010; 22: 829\u2013838.","journal-title":"J Alzheimers Dis"},{"key":"BFmp2016120_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000321234","volume":"20","author":"EF van Rossum","year":"2011","unstructured":"van Rossum EF, van den Akker EL . Glucocorticoid resistance. Endocr Dev 2011; 20: 127\u2013136.","journal-title":"Endocr Dev"},{"key":"BFmp2016120_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/mp.2011.145","volume":"18","author":"W El-Hage","year":"2013","unstructured":"El-Hage W, Phillips ML, Radua J, Gohier B, Zelaya FO, Collier DA et al. Genetic modulation of neural response during working memory in healthy individuals: interaction of glucocorticoid receptor and dopaminergic genes. Mol Psychiatry 2013; 18: 174\u2013182.","journal-title":"Mol Psychiatry"},{"key":"BFmp2016120_CR31","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","volume":"29","author":"AH Young","year":"2004","unstructured":"Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN . Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 2004; 29: 1538\u20131545.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2016120_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/mp.2014.57","volume":"19","author":"AF Schatzberg","year":"2014","unstructured":"Schatzberg AF, Keller J, Tennakoon L, Lembke A, Williams G, Kraemer FB et al. HPA axis genetic variation, cortisol and psychosis in major depression. Mol Psychiatry 2014; 19: 1151.","journal-title":"Mol Psychiatry"},{"key":"BFmp2016120_CR33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.biopsych.2007.04.013","volume":"62","author":"R Kumsta","year":"2007","unstructured":"Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wust S . Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol Psychiatry 2007; 62: 863\u2013869.","journal-title":"Biol Psychiatry"},{"key":"BFmp2016120_CR34","doi-asserted-by":"crossref","unstructured":"de Kloet ER, Otte C, Kumsta R, Kok L, Hillegers MH, Hasselmann H et al. STRESS and DEPRESSION a crucial role of the mineralocorticoid receptor. J Neuroendocrinol 2016.","DOI":"10.1111\/jne.12379"},{"key":"BFmp2016120_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.neuroscience.2014.12.004","volume":"286","author":"DA Hamstra","year":"2015","unstructured":"Hamstra DA, de Kloet ER, van Hemert AM, de Rijk RH, Van der Does AJ . Mineralocorticoid receptor haplotype, oral contraceptives and emotional information processing. Neuroscience 2015; 286: 412\u2013422.","journal-title":"Neuroscience"},{"key":"BFmp2016120_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-244X-7-32","volume":"7","author":"SL Naismith","year":"2007","unstructured":"Naismith SL, Longley WA, Scott EM, Hickie IB . Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry 2007; 7: 32.","journal-title":"BMC Psychiatry"},{"key":"BFmp2016120_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1017\/S003329170800411X","volume":"39","author":"S Reppermund","year":"2009","unstructured":"Reppermund S, Ising M, Lucae S, Zihl J . Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychol Med 2009; 39: 603\u2013614.","journal-title":"Psychol Med"},{"key":"BFmp2016120_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jad.2006.02.008","volume":"92","author":"CE Wang","year":"2006","unstructured":"Wang CE, Halvorsen M, Sundet K, Steffensen AL, Holte A, Waterloo K . Verbal memory performance of mildly to moderately depressed outpatient younger adults. J Affect Disord 2006; 92: 283\u2013286.","journal-title":"J Affect Disord"},{"key":"BFmp2016120_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1037\/a0017336","volume":"24","author":"SM McClintock","year":"2010","unstructured":"McClintock SM, Husain MM, Greer TL, Cullum CM . Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology 2010; 24: 9\u201334.","journal-title":"Neuropsychology"},{"key":"BFmp2016120_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.04.022","volume":"119","author":"LM McDermott","year":"2009","unstructured":"McDermott LM, Ebmeier KP . A meta-analysis of depression severity and cognitive function. J Affect Disord 2009; 119: 1\u20138.","journal-title":"J Affect Disord"},{"key":"BFmp2016120_CR41","first-page":"233","volume":"14","author":"NI Landro","year":"2001","unstructured":"Landro NI, Stiles TC, Sletvold H . Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 233\u2013240.","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"BFmp2016120_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1017\/S0033291702007018","volume":"33","author":"FC Murphy","year":"2003","unstructured":"Murphy FC, Michael A, Robbins TW, Sahakian BJ . Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance. Psychol Med 2003; 33: 455\u2013467.","journal-title":"Psychol Med"},{"key":"BFmp2016120_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12017-012-8202-1","volume":"15","author":"ME Fortier","year":"2013","unstructured":"Fortier ME, Sengupta SM, Grizenko N, Choudhry Z, Thakur G, Joober R . Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response. Neuromolecular Med 2013; 15: 122\u2013132.","journal-title":"Neuromolecular Med"},{"key":"BFmp2016120_CR44","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s12020-014-0324-9","volume":"47","author":"YX Yan","year":"2014","unstructured":"Yan YX, Dong J, Zhang J, Liu F, Wang W, Zhang L et al. Polymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population. Endocrine 2014; 47: 740\u2013748.","journal-title":"Endocrine"},{"key":"BFmp2016120_CR45","first-page":"214","volume":"26","author":"D Lasic","year":"2014","unstructured":"Lasic D, Bevanda M, Bosnjak N, Uglesic B, Glavina T, Franic T . Metabolic syndrome and inflammation markers in patients with schizophrenia and recurrent depressive disorder. Psychiatr Danub 2014; 26: 214\u2013219.","journal-title":"Psychiatr Danub"},{"key":"BFmp2016120_CR46","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2337\/dc08-0985","volume":"31","author":"B Mezuk","year":"2008","unstructured":"Mezuk B, Eaton WW, Albrecht S, Golden SH . Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31: 2383\u20132390.","journal-title":"Diabetes Care"},{"key":"BFmp2016120_CR47","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/archinternmed.2010.356","volume":"170","author":"A Pan","year":"2010","unstructured":"Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 2010; 170: 1884\u20131891.","journal-title":"Arch Intern Med"},{"key":"BFmp2016120_CR48","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.mehy.2006.09.065","volume":"68","author":"GP Vinson","year":"2007","unstructured":"Vinson GP . Angiotensin II, corticosteroids, type II diabetes and the metabolic syndrome. Med Hypotheses 2007; 68: 1200\u20131207.","journal-title":"Med Hypotheses"},{"key":"BFmp2016120_CR49","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1210\/jc.2006-2540","volume":"92","author":"H Bruehl","year":"2007","unstructured":"Bruehl H, Rueger M, Dziobek I, Sweat V, Tirsi A, Javier E et al. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 2439\u20132445.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFmp2016120_CR50","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00125-007-0602-7","volume":"50","author":"SM Gold","year":"2007","unstructured":"Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007; 50: 711\u2013719.","journal-title":"Diabetologia"},{"key":"BFmp2016120_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/TACG.S39993","volume":"7","author":"C Gragnoli","year":"2014","unstructured":"Gragnoli C . Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome. Appl Clin Genet 2014; 7: 43\u201353.","journal-title":"Appl Clin Genet"},{"key":"BFmp2016120_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jad.2011.06.020","volume":"134","author":"A Szczepankiewicz","year":"2011","unstructured":"Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Rajewska-Rager A, Dmitrzak-Weglarz M, Wilkosc M et al. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. J Affect Disord 2011; 134: 138\u2013144.","journal-title":"J Affect Disord"},{"key":"BFmp2016120_CR53","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00702-013-1012-2","volume":"120","author":"DL Rovaris","year":"2013","unstructured":"Rovaris DL, Mota NR, de Azeredo LA, Cupertino RB, Bertuzzi GP, Polina ER et al. MR and GR functional SNPs may modulate tobacco smoking susceptibility. J Neural Transm 2013; 120: 1499\u20131505.","journal-title":"J Neural Transm"},{"key":"BFmp2016120_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/YPG.0b013e32833a2142","volume":"20","author":"E Cellini","year":"2010","unstructured":"Cellini E, Castellini G, Ricca V, Bagnoli S, Tedde A, Rotella CM et al. Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. Psychiatr Genet 2010; 20: 282\u2013288.","journal-title":"Psychiatr Genet"},{"key":"BFmp2016120_CR55","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/00019442-200505000-00002","volume":"13","author":"TM Buckley","year":"2005","unstructured":"Buckley TM, Schatzberg AF . Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation. Am J Geriatr Psychiatry 2005; 13: 344\u2013352.","journal-title":"Am J Geriatr Psychiatry"},{"key":"BFmp2016120_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.psyneuen.2013.11.010","volume":"40","author":"S Vogel","year":"2014","unstructured":"Vogel S, Gerritsen L, van Oostrom I, Arias-Vasquez A, Rijpkema M, Joels M et al. Linking genetic variants of the mineralocorticoid receptor and negative memory bias: interaction with prior life adversity. Psychoneuroendocrinology 2014; 40: 181\u2013190.","journal-title":"Psychoneuroendocrinology"},{"key":"BFmp2016120_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0065-2660(07)00414-2","volume":"60","author":"N Liu","year":"2008","unstructured":"Liu N, Zhang K, Zhao H . Haplotype-association analysis. Adv Genet 2008; 60: 335\u2013405.","journal-title":"Adv Genet"},{"key":"BFmp2016120_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.psychres.2012.09.025","volume":"207","author":"A Leszczynska-Rodziewicz","year":"2013","unstructured":"Leszczynska-Rodziewicz A, Szczepankiewicz A, Dmitrzak-Weglarz M, Rajewska-Rager A, Skibinska M, Hauser J . No association between polymorphisms and haplotypes of the AVPR1b, CRHR1 and NR3C1 genes and depression with melancholic features in the course of bipolar disorder. Psychiatry Res 2013; 207: 140\u2013142.","journal-title":"Psychiatry Res"},{"key":"BFmp2016120_CR59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.psyneuen.2015.02.013","volume":"55","author":"F Hardeveld","year":"2015","unstructured":"Hardeveld F, Spijker J, Peyrot WJ, de Graaf R, Hendriks SM, Nolen WA et al. Glucocorticoid and mineralocorticoid receptor polymorphisms and recurrence of major depressive disorder. Psychoneuroendocrinology 2015; 55: 154\u2013163.","journal-title":"Psychoneuroendocrinology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2016120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2016120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2016120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:43:51Z","timestamp":1648766631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2016120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFmp2016120"],"URL":"https:\/\/doi.org\/10.1038\/mp.2016.120","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]},"assertion":[{"value":"28 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Although there is not a conflict of interest, there may appear to be one with Dr Schatzberg. He has a significant interest in Corcept Therapeutics, which licensed the use patent for mifepristone in psychotic major depression. Some of the data presented here were part of a larger study examining the effectiveness of mifepristone in psychotic major depression. No data on mifepristone\u2019s effectiveness are presented in the submitted report. Several authors have been named on a use patent related to the SNPs reported in this manuscript, including Alan Schatzberg, Greer Murphy and Jennifer Keller. Dr Greer Murphy has been a consultant for Brain Resource.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}